Nephrocare Health Services Board Meeting November 3

Board Meeting Details

A meeting of the Board of Directors is scheduled to be held on Tuesday, November 3, 2026. The primary agenda is to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026.

Trading Window Closure

In continuation of the company's intimation dated September 25, 2026, the trading window for dealing in the securities of the Company remains closed for all Designated Persons and their immediate relatives. The closure period is from October 1, 2026, to November 5, 2026 (both days inclusive).